21619-25-0 Usage
Uses
Used in Pharmaceutical Synthesis:
4-bromopentane-2,3-dione is used as an intermediate in the synthesis of pharmaceuticals for its reactivity and ability to be incorporated into various organic compounds.
Used in Organic Synthesis:
4-bromopentane-2,3-dione serves as a reagent in organic synthesis, contributing to the formation of complex organic molecules.
Used in Academic and Industrial Laboratories:
4-bromopentane-2,3-dione is utilized in both academic and industrial laboratories for the production of various pharmaceuticals and organic compounds due to its versatility and reactivity.
Used in the Preparation of α-bromoketones:
As a building block, 4-bromopentane-2,3-dione is used in the preparation of α-bromoketones, which are important intermediates in the synthesis of a wide range of organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 21619-25-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,6,1 and 9 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 21619-25:
(7*2)+(6*1)+(5*6)+(4*1)+(3*9)+(2*2)+(1*5)=90
90 % 10 = 0
So 21619-25-0 is a valid CAS Registry Number.
21619-25-0Relevant academic research and scientific papers
THIAZOLOPYRIMIDINONES AS MODULATORS OF NMDA RECEPTOR ACTIVITY
-
Paragraph 0352, (2015/04/28)
The present invention relates to certain thiazolopyrimidinone compounds for use in modulating NMDA receptor activity, pharmaceutical compositions comprising such compounds and methods of treating neurological and psychiatric conditions.
Azole derivatives as histamine H3 receptor antagonists, Part I: Thiazol-2-yl ethers
Walter,Von Coburg,Isensee,Sander,Ligneau,Camelin,Schwartz,Stark
supporting information; experimental part, p. 5879 - 5882 (2010/11/18)
Most human histamine H3 receptor (hH3R) antagonists follow a general structural blueprint, containing a basic moiety linked by a spacer to a substituted core element. In this investigation the acceptance of thiazol-2-yl ether moieties in the core region is proved with some ether derivatives showing hH3R binding affinities in the nanomolar concentration range. A diversity of structural motifs is used as substituents to enhance the in vitro hH3R binding affinity.
